US Patent Issued to ZYMEWORKS BC on Oct. 7 for "Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancers" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,157, issued on Oct. 7, was assigned to ZYMEWORKS BC INC. (Vancouver, Canada).

"Methods of using a bispecific antigen-binding construct targeting HER2 for the treatment of biliary tract cancers" was invented by Diana F. Hausman (Seattle), Neil C. Josephson (Seattle), Rose Kamyee Lai (Seattle), Gerald James Rowse (Vancouver, Canada) and Patrick Kaminker (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is a method of treating biliary tract cancer (BTC) comprising administering a bispecific antigen-binding construct targeting HER2 or a bispecific antigen-binding construct targeting HER2 linked to an auristatin analogue (ADC) to a ...